Clinical trial
Botswana Tenofovir Oral HIV Prophylaxis Trial
NCT00111150 · Centers for Disease Control and Prevention, U.S. Fed · Terminated
Key facts
| NCT number | NCT00111150 |
|---|---|
| Title | Botswana Tenofovir Oral HIV Prophylaxis Trial |
| Official title | Study of the Safety and Efficacy of Daily Tenofovir Disoproxil Fumarate for the Prevention of HIV Infection in Heterosexually Active Young Adults in Botswana |
| Lead sponsor | Centers for Disease Control and Prevention, U.S. Fed |
| Collaborators | Botswana Ministry of Health Gilead Sciences Industry |
| Status | Terminated |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | HIV Infection |
| Intervention type | Drug |
| Interventions | Tenofovir Disoproxil Fumarate 300 mg daily |
| Enrollment | 1,200 |
| Start date | Sep 1, 2005 |
| Completion | Mar 1, 2007 |
| First posted | May 18, 2005 |
| Last update posted | Mar 19, 2007 |
| Countries | Botswana, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: